Skip to main content
Trial shows Bio2's catheter-filter combo effective against pulmonary embolism

A 163-patient pivotal study showed use of Bio2 Medical's Angel combined IVC filter/central venous catheter in critically ill patients who had a high risk of acute pulmonary embolism and contraindications to anticoagulation significantly reduced clinically significant and fatal pulmonary embolism without device-related bloodstream infections in more than 1,170 days. The trial met its safety endpoints, and the device was placed and removed without incident in all patients.

Full Story: